Currently, no universal diagnostic test will tell you the coagulation status of a patient, agnostic to their anticoagulant drug, despite the growing need.
As companies reexamine their supply chains, Jim Medsker of Keystone Solutions Group explains how his firm is handling reshoring requests from medtech OEMs.